Protalix Biotherapeutics, Inc. (PLX)
2.04
-0.02
(-0.97%)
USD |
NYAM |
Jan 16, 16:00
2.05
+0.01
(+0.49%)
After-Hours: 20:00
Protalix Biotherapeutics Market Cap: 164.06M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| OraSure Technologies, Inc. | 192.96M |
| PAVmed, Inc. | 6.062M |
| Denali Therapeutics, Inc. | 2.809B |
| AIM ImmunoTech, Inc. | 3.942M |
| Armata Pharmaceuticals, Inc. | 232.51M |
Market Cap Related Metrics
| PE Ratio | 29.35 |
| PS Ratio | 2.594 |
| Price to Book Value | 3.101 |
| Price | 2.04 |
| Earnings Yield | 3.41% |
| Operating PE Ratio | 25.20 |
| Normalized PE Ratio | 29.35 |